Bayzed Health Group Inc

Research Bayzed Health Group Inc (2609.HK) on Bullrun: market cap HKD 3.51B, P/E 133.0. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 3.51B; P/E is 133.0.

Peer valuation comparison

Latest P/E is 133x versus a Healthcare sector median of 21.69x (513.1% above).

Latest P/E is 133x versus a China median of 16.26x (717.8% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 1.12B-CNY 12.96MCNY 184.43M17.0%-0.01CNY 607.36MCNY 544.40MCNY 1.52B
FY2024CNY 1.19B-CNY 13.46MCNY 122.09M17.5%-0.01CNY 275.97MCNY 517.26MCNY 1.07B
FY2023CNY 1.07B-CNY 26.39MCNY 74.56M16.6%-0.02CNY 241.99MCNY 530.27MCNY 1.08B
FY2022CNY 802.65M-CNY 58.02MCNY 78.05M9.9%-0.04CNY 125.19MCNY 457.61MCNY 987.90M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 3.51B133.0n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About Bayzed Health Group Inc

Bayzed Health Group Inc operates and manages a network of hospitals that provides oncology medical and healthcare services in the People's Republic of China. The company offers screening, diagnosis, treatment, and rehabilitation services. It also provides hospital management services; and supplies pharmaceuticals, medical equipment, and consumables. The company was founded in 2017 and is headquartered in Beijing, the People's Republic of China. The company was founded in 2017 and is based in Beijing, China.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Bayzed Health Group Inc's market cap?

Bayzed Health Group Inc's market capitalization is HKD 3.51B.

What is Bayzed Health Group Inc's P/E ratio?

Bayzed Health Group Inc's price-to-earnings (P/E) ratio is 133.0.

What does Bayzed Health Group Inc do?

Bayzed Health Group Inc operates and manages a network of hospitals that provides oncology medical and healthcare services in the People's Republic of China. The company offers screening, diagnosis, treatment, and rehabilitation services. It also provides hospital management services; and supplies pharmaceuticals, medical equipment, and consumables. The company was founded in 2017 and is headquartered in Beijing, the People's Republic of China. The company was founded in 2017 and is based in Beijing, China.